Joel Lewis, President and CEO at GALECTIN THERAPEUTICS INC (GALT), sold 15,658 shares at $7.06 ($111K) on 2025-12-17, disclosed to the SEC on 2025-12-19.
Scheduled sale ($111k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.06 | 7,829 | $55K | 50.0% |
| 2 | $7.06 | 7,829 | $55K | 50.0% |
| Total | $7.06 avg | 15,658 | $111K | 100% |
| Filing → |
| GALT | SELL | 2025-11-12 | $11K | — | Filing → |
| GALT | SELL | 2025-11-07 | $1K | — | Filing → |
| GALT | SELL | 2025-11-05 | $183K | — | Filing → |